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The field of cardiovascular medicine has experienced tre-
mendous growth and progress in the 50 years since the
American College of Cardiology (ACC) was founded. Since
1949, we have witnessed remarkable progress in our under-
standing of the pathogenesis and pathophysiology of car-
diovascular disease (CVD) and the emergence of the new
diagnostic modalities, effective therapies and prevention
strategies that have reduced the age-adjusted mortality rate
from CVD by nearly 60%. Despite this impressive reduction
in the death rate for CVD, the growth in the prevalence of
chronic heart and vascular disease is predicted to be twice
that of the growth of the general population in the first 20
years of the new millennium (1).
In December, as part of the ACC’s fiftieth anniversary
celebration, the College invited three leading futurists to
consider the impact that changing demographics, technol-
ogy and costs will have on the future of cardiovascular care.
These experts collaborated with working groups of ACC
members and then presented their predictions at the ACC
Forum on the Future in New York City, December 3, 1999.
In addition to the groups that focused on forthcoming
changes in demographics, technology and cost, a fourth
group composed exclusively of ACC members developed an
article examining what the College’s response to the pre-
dicted changes in these three areas should be. After the
articles were presented during the morning of the forum,
and a lively discussion had taken place, the four groups
spent the afternoon revising their articles. The results of
their efforts were published in the March 15, 2000, issue of
the Journal (2–5).
MORE PEOPLE WITH CVD
When experts gaze into the future, they see many more
people with CVD. According to David K. Foot, PhD, of
the University of Toronto, and the Demographics Working
Group chaired by Richard P. Lewis, MD, the aging of the
Baby Boom generation will cause the number of cases of
chronic heart disease to skyrocket. His calculations suggest
a projection that deaths from heart disease will increase by
128.5% between 2000 and 2050, associated with a whop-
ping 93% increase in the prevalence of heart disease in the
same time period.
To meet this challenge, the Demographics Working
Group stressed the need to begin recruiting new cardiolo-
gists now. There will be a need for more cardiovascular
specialists to enter the workforce as patient loads, patient
complexity and the number of cardiovascular operations and
procedures increase. During the next 15 years, we must
develop a strategy to attract the best and brightest children
of the Boomers into the profession to provide optimal
cardiovascular care to their aging parents.
TECHNOLOGICAL ADVANCES
AND ACCOMPANYING ETHICAL DILEMMAS
New technologies will also help us to meet the challenges
posed by an aging society. Although technological innova-
tions are notoriously difficult to predict, Joe Flower, of the
What If . . . , and the Technology Working Group chaired
by Leonard S. Dreifus, MD, provided an exciting glimpse of
what the future might look like. Over the next decade, after
the Human Genome Project is completed, preclinical ge-
netic diagnosis will become available so that individuals can
undergo genetic screening early in life and receive their
individual risk profiles for various CVDs and lipid disorders.
Advances in molecular genetics will also permit the use of
recombinant genes as therapies to treat CVD. This will lead
to the introduction of an entirely new class of pharmaceu-
ticals during the next decade, together with angiogenesis
and myogenesis drugs. There are predictions that swine
hearts will replace human hearts for transplantation and that
mechanical replacement hearts will become more common.
Later, in the first quarter of the new century, replacement
organs grown in the laboratory using stem cell technology
could become a reality. Nanotechnology will permit delivery
of pharmaceuticals to precisely targeted locations, and
minute sensing devices will be produced that can be injected
into the bloodstream to register biologic information to be
recorded by outside monitors. These are only a few of the
predicted advances, but we all know that many yet undis-
covered technologies will emerge that will be effective in
detecting and treating both preclinical and established
CVD.
Not surprisingly, Mr. Flower’s predictions prompted
lively debate. But no matter what the future actually brings,
we can all agree that cardiovascular medicine will continue
to be at the nexus of both biological and information
technologies. Great ethical debates can be expected with
respect to such issues as privacy regarding genetic screening
and the transplanting of animal hearts into humans.
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RISING COSTS
Cost, of course, is a crucial issue as we consider the future.
According to Donald M. Steinwachs, PhD, of the Johns
Hopkins School of Hygiene and Public Health, and the
Cost Structures Working Group chaired by Ruth L.
Collins-Nakai, MD, heart disease–related expenditures will
increase by 54% during the next 25 years. Costs for heart
diseases are projected to increase to $157 billion annually by
2025. Although the introduction of new pharmaceuticals
could reduce use of expensive invasive procedures, and the
use of porcine hearts could lower transplantation costs, the
successful treatment brought about by these and other
innovations will lengthen people’s lives and thus increase
overall health care expenses. Our aging population will be
the main force driving up costs for heart disease care. In his
presentation, Dr. Steinwachs commented that the average
cost of heart disease is more than four times higher for
people over age 75 than for those under age 65.
Dr. Steinwachs and his group noted that the current
financing of health care is already inadequate, and they
described several scenarios for paying our health care bills of
the future. The economy could grow enough to accommo-
date increased costs, they suggested, or the nation could
invest in finding ways to make health care dollars go further.
Alternatively, the future could find us falling deeper into a
system in which the level of care depends on the ability to
pay. We may well be headed toward the latter scenario and
the disenfranchisement of more and more segments of the
population. The only solution is to find a way to provide
health care coverage for all Americans.
THE COLLEGE’S ROLE
How will the ACC respond to these changes? The ACC
Response Working Group, chaired by Francis J. Klocke,
MD, is stressing the importance of flexibility. As needs
change, so will the resources and emphasis allocated to each
of the College’s major goals: education, advocacy and
clinical standard setting. The mission of the ACC has
always been and will continue to be fostering optimal
cardiovascular care and disease prevention. Because of the
talent and spirit of volunteerism of its members, and the
high quality of its staff, the College will strive to accomplish
its mission in the face of the predicted changes in demo-
graphics, the emergence of new technology and the rising
demand for and costs of health care. The College, whose
history evidences its continuing ability to evolve and adapt
to changing times and its members’ changing needs, will
find new ways to help members adjust to challenges such as
the changing roles of both clinicians and patients, the
impact of the information age, and the need to be a practice
manager as well as a practitioner. Promotion of research,
translation of research findings into practice guidelines, and
standard setting will remain high priorities for the ACC.
One thing is sure: The College will continue to be the best
and most relevant source of cardiovascular medical educa-
tion, practice guidelines and advocacy for all of us, and for
all of our patients, who are concerned with fighting CVD.
Many thanks to all of the people whose hard work helped
to make the Forum on the Future such a success. Here’s to
another 50 years of excellence.
I welcome your own thoughts about the future of cardio-
vascular medicine. Please feel free to write to me at Heart
House, 9111 Old Georgetown Road, Bethesda, MD
20814-1699; fax me at (301) 897-9745; or email me at
pres@acc.org.
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